Salil Vasudeo Deo

Salil Vasudeo Deo

Auto-generated profile, based on publicly available information

Salil Vasudeo Deo

Case School of Medicine, Case Western Reserve University, Cleveland, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2021 in Indian Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
SDSalil Vasudeo Deo
Salil Vasudeo Deo
VDVaishali Deo
Vaishali Deo
VSVarun Sundaram
Varun Sundaram

1 December 2018 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
CCCarolyn Chang
Carolyn Chang
SRSajjad Raza
Sajjad Raza
SASalah E. Altarabsheh
Salah E. Altarabsheh
SDSarah DeLozier
Sarah DeLozier
USUmesh M. Sharma
Umesh M. Sharma
SDSalil V. Deo
Salil V. Deo

1 February 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
SDSalil V. Deo
Salil V. Deo
SASadeer G. Al-Kindi
Sadeer G. Al-Kindi
SASalah E. Altarabsheh
Salah E. Altarabsheh
DHDustin Hang
Dustin Hang
SKSachin Kumar
Sachin Kumar
SPSoon J. Park
Soon J. Park

19 May 2015 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
JLJu Yong Lim
Ju Yong Lim
SDSalil V. Deo
Salil V. Deo
ARAbeer Rababah
Abeer Rababah
SASalah E. Altarabsheh
Salah E. Altarabsheh
YCYang Hyun Cho
Yang Hyun Cho
SPSoon J. Park
Soon J. Park
Levosimendan is implemented in patients with low cardiac output after cardiac surgery. However, the strength of evidence is limited by randomized controlled trials enrolling a small number of patients. Hence we have conducted a systematic review to determine the role of levosimendan in adult cardiac surgery. PUBMED, WoS, Cochrane database, and SCOPUS were systematically queried to identify original English language peer-reviewed literature (inception-October 2014) comparing clinical results of adult cardiac surgery between levosimendan and control. Pooled odds ratio (OR) was calculated using the Peto method; p < 0.05 is significant; results are presented within 95% confidence intervals. Continuous data was compared using standardized mean difference/mean difference. Fourteen studies were included in the analysis. Levosimendan reduced early mortality in patients with reduced ejection fraction (5.5% vs. 9.1%) (OR 0.48 [0.23-0.76]; p = 0.004). This result was confirmed using sensitivity analysis. Postoperative acute renal failure was lower with levosimendan therapy (7.4% vs. 11.5%). Intensive care unit stay was shorter in the levosimendan cohort comparable in both groups (standardized mean difference -0.31 [-0.53, -0.09]; p = 0.006; I(2) = 33.6%). Levosimendan-treated patients stayed 1.01 (1.61-0.42) days shorter when compared to control (p = 0.001). Our meta-analysis demonstrates that Levosimendan improves clinical outcomes in patients with left ventricular dysfunction undergoing cardiac surgery. Results of the ongoing multicenter randomized controlled trial are awaited to provide more conclusive evidence regarding the benefit of this drug.

16 February 2021 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
PDF file
PDPiroze M. Davierwala
Piroze M. Davierwala
AVAlexander Verevkin
Alexander Verevkin
LBLaura Bergien
Laura Bergien
KAKonstantin von Aspern
Konstantin von Aspern
SDSalil V. Deo
Salil V. Deo
MBMichael A. Borger
Michael A. Borger

3 September 2024 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
PSPedro Rafael Vieira de Oliveira Salerno
Pedro Rafael Vieira de Oliveira Salerno
ACAntoinette Cotton
Antoinette Cotton
YEYakov E. Elgudin
Yakov E. Elgudin
SVSalim Virani
Salim Virani
KNKhurram Nasir
Khurram Nasir
SDSalil V. Deo
Salil V. Deo
Importance: It is not well understood if and how various social and environmental determinants of health (SEDoH) are associated with mortality rates related to cardio-kidney-metabolic syndrome (CKM) across the US.Objective: To study the magnitude of the association strength of SEDoH with CKM-related mortality at the county level across the US.Design, Setting, and Participants: This cross-sectional, retrospective, population-based study used aggregate county-level data from the US Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (WONDER) data portal from 2010-2019. Data analysis occurred from September 2023 to January 2024.Exposures: A total of 7 diverse SEDoH were chosen, including median annual household income, percentage of racial and ethnic minority residents per county, fine particulate air pollution (PM2.5) concentrations, high-school completion rate, primary health care access, food insecurity, and rurality rate.Main Outcomes and Measures: The primary outcome was county-level age-adjusted mortality rate (aaMR) attributable to CKM. The association of county-level CKM-related aaMR with the 7 SEDoH was analyzed using geographically weighted models and the model median coefficients for each covariate studied.Results: Data from 3101 of 3243 counties (95.6%) were analyzed. There was substantial variation in SEDoH between states and counties. The overall pooled median (IQR) aaMR (2010-2019) in the US was 505.5 (441.3-578.9) per 100 000 residents. Most counties in the lower half of the US had rates much higher than the pooled median (eg, Southern US median [IQR] aaMR, 537.3 [466.0-615.9] per 100 000 residents). CKM-related mortality was positively associated with the food insecurity rate (median [IQR] β = 6.78 [2.78-11.56]) and PM2.5 concentrations (median [IQR] β = 5.52 [−11.06 to 19.70]), while it was negatively associated with median annual household income (median [IQR] β = −0.002 [−0.003 to −0.001]), rurality (median [IQR] β = −0.32 [−0.67 to 0.02]), high school completion rate (median [IQR] β = −1.89 [−4.54 to 0.10]), racial and ethnic minority rate (median [IQR] β = −0.66 [−1.85 to 0.89]), and primary health care access rate (median [IQR] β = −0.18 [−0.35 to 0.07]).Conclusions and Relevance: In this cross-sectional study of county-level data across the US, there were substantial geographical differences in the magnitude of the association of SEDoH with CKM-related aaMR. These findings may provide guidance for deciding local health care policy.